🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to compare the safety and efficacy of an aromatase inhibitor in com...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05-05
Trial ID
NCT01160211
Treatments Being Tested
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone th...
Status
Unknown
Location
Federico II University Medical School
Start Date
2008-05
Trial ID
NCT00688194
Treatments Being Tested
This study evaluated and compared the efficacy and tolerability of lapatini...
Status
Completed
Location
Novartis Investigative Site
Start Date
2003-12-09
Trial ID
NCT00073528
The purpose of this study is to find out what effects, administering infusi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01361945
Treatments Being Tested
Cross-talk between epidermal growth factors and the ER occurs at multiple l...
Status
Completed
Location
Asan Nedical Center
Start Date
2010-09
Trial ID
NCT01275859
Treatments Being Tested
Non-randomized, open label, multicentric translational research study in wo...
Status
Completed
Location
Hospital de Torrevieja
Start Date
2013-10
Trial ID
NCT01973660
Treatments Being Tested
Breast cancer is the most common malignancy in the U.S. Targeted therapies ...
Status
Active Not Recruiting
Location
University of Alabama - Birmingham
Start Date
2011-10
Trial ID
NCT00999804
Treatments Being Tested
SHIVA is a proof of concept randomized phase II trial which compares two tr...
Status
Completed
Location
Centre régional de lutte contre le cancer de Bourgogne Georges François Leclerc
Start Date
2012-10
Trial ID
NCT01771458
Treatments Being Tested
The purpose of this study is to determine if BMS-690514 + letrozole will be...
Status
Completed
Location
Texas Oncology-Abilene
Start Date
2010-06
Trial ID
NCT01068704
Treatments Being Tested
The HER2 status in breast cancer patients may change during the course of t...
Status
Completed
Location
University Hospital Ulm
Start Date
2012-02
Trial ID
NCT01619111
Treatments Being Tested